AzTrials
AzTrials

Advanced DementiaPROSPECTNCT04779684

Promoting Self-determination for Institutionalized Older People Without Decision-making Capacity: Advance Care Planning by Proxy

A study testing Advance care planning by proxy for health care proxies of people without medical decision making capacity in people with Advanced Dementia and Loss of Medical Decision Making Capacity, run by Ralf J. Jox at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to test the acceptability and feasibility of an advance care planning (ACP) intervention which has been developed to be used with the health care proxies of residential aged care facility (RACF) residents who no longer have decision making capacity for medical decisions. Read more about this study

Who is it for?
Ages 70 to 110 years
What is being tested?
Advance care planning by proxy for health care proxies of people without medical decision making capacity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSwitzerland
Study dates
1 Aug 2021to 31 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 to 110 years
  • All sexes
  • No healthy volunteers
  • Older adult

Health Care Proxy Inclusion Criteria:

  • Is the legally authorized health care proxy for an RACF resident who: no longer has medical decision making capacity (according to medical judgement), is over 70 years of age and lives in an RACF in the canton of Vaud;
  • Has sufficient language proficiency to complete a written questionnaire and participate in discussions.

Health Care Proxy Exclusion Criteria:

  • Has insufficient language proficiency to complete a written questionnaire and participate in discussions.
  • Lacks decision making capacity

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Lausanne University Hospital

    Lausanne, Canton of Vaud, 1011

Other trials in Switzerland

About this study

This study aims to test the acceptability and feasibility of an advance care planning (ACP) intervention which has been developed to be used with the health care proxies of residential aged care facility (RACF) residents who no longer have decision making capacity for medical decisions. The intervention involves two discussions that are facilitated by a trained health professional. The first discussion aims to discuss the resident's life story, values, previous medical treatments and experiences with illness and death and whether or not they have previously documented their wishes for future care. The second discussion also involves the treating physician and aims to document anticipatory decisions for emergency situations. Follow-up discussions after 12 months or any change in situation will be conducted.

Read the detailed description

Patient-centered care involves treating patients in the way that is the most aligned with their values and their self-determination. This is the aim of Advance Care Planning (ACP), a communication-based complex intervention. ACP involves accompanied reflection about one's values, anticipation of potential health problems in future states of impaired decision-making capacity, consideration of a range of treatment and care options, anticipatory decision making and the documentation and communication of these decisions to family members and health care professionals. This process ensures that a person's self-determination is respected even when she is no longer able to make health care decisions. ACP programs are well established in the English-speaking world and are currently being developed across Asia and Europe.

Participation in ACP requires decision-making capacity. Yet, many people lose this capacity before having formally expressed their care preferences. In these cases, their health care proxies, families and health professionals are called upon to make decisions on their behalf, based on what they believe the person would have wanted (presumed will). This is problematic and distressing for both family members and health professionals. The fact that many people do not participate in ACP or complete advanced directives, along with an increasing prevalence of neuro-degenerative diseases entailing a loss of decision-making capacity, means that growing numbers of people are likely to require others to make medical decisions on their behalf.

The investigator's exploratory research, confirmed by the literature, highlights an urgent unmet need for comprehensive and systematic interventions to assist in promoting self-determination of older people who lack decision making capacity. ACP by proxy (ACP-bp) has been suggested as a model to help proxies of incapacitated patients plan ahead and prepare for future care decisions. However, this model has never been specifically developed nor tested. This is why the investigators have developed a specific model of ACP-bp and aim to test it in a pilot study among proxies of residential aged care facility (RACF) residents who lack decision making capacity, primarily due to advanced dementia.

The investigators aim to test the acceptability and feasibility of this intervention and the appropriateness of outcome measures through a pilot study in two RACFs in the Swiss canton of Vaud over a period of one year. A process evaluation will be conducted through the triangulation of mixed-method data: self-report scales, semi-structured interviews, document analyses, resident health care records and an economic cost analysis. This will form the basis for a subsequent cluster-randomized control trial to test the intervention's effectiveness. This novel approach of ACP-bp has potential to promote self-determination and patient-centered care that improves both the ethical appropriateness and economic sustainability of care. It may lead to patients being treated in accordance with their wishes, reduce unnecessary overtreatment and avoid distress for family members and health care professionals. This approach also responds to calls for models of ACP which can be used in people with dementia and people living in RACFs, vulnerable populations that have generally remained invisible in ACP research so far.

Being tested
Advance care planning by proxy for health care proxies of people without medical decision making capacity
Keywords
Advance Care Planning by proxy, Surrogate decision making, Advanced Dementia, Decision making capacity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Advance care planning by proxy for health care proxies of people without medical decision making capacityOther

    Two discussions between a trained health professional and a health care proxy of an RACF resident who no longer has decision making capacity. First discussion focuses on life story, values, previous experiences with medical treatments, illness and death. Second discussion also includes treating physician and focuses on establishing general goals of care and medical orders in case of emergency.

Study groups in NCT04779684
Study groupRoleWhat they receive
ACP by proxy pilot intervention groupExperimentalAll participants are included in the intervention group
Receives: Other: Advance care planning by proxy for health care proxies of people without medical decision making capacity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the ACP by proxy intervention

    Acceptability of the intervention from the perspectives of health care proxies, RACF health professionals and physicians will be assessed through qualitative interviews asking about their experiences of the intervention. Interviews will be conducted 12 months after the start of the intervention

    Measured: 12 months

  2. Feasibility of the ACP by proxy intervention in RACFs

    Feasibility of the intervention from the perspectives of health care proxies, RACF health professionals and physicians will be assessed through qualitative interviews asking about their experiences of the intervention. Interviews will be conducted 12 months after the start of the intervention.

    Measured: 18 month

Secondary outcomes (2)
  1. Decisional conflict

    Health care proxy decisional conflict in making decisions on behalf of an RACF resident who no longer has medical decision making capacity (as measured by the Decisional Conflict Scale). Higher scores indicate more decisional conflict (minimum score: 0, maximum score: 64).

    Measured: 18 months

  2. Self-efficacy in giving care concordent with resident wishes

    Health professional self-efficacy in providing care that is consistent with the wishes of a person who no longer has medical decision making capacity will be assessed through a single item numerical rating scale from 1-10 (higher scores indicate more self-efficacy)

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2021
  2. Study start1 Aug 2021
  3. Primary completion30 Oct 2023
  4. Study completion31 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Pilot study of acceptability and fesability
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04779684
Sponsor's protocol ID
ACPbp
Acronym
PROSPECT
Status last verified
Nov 2023
First submitted
23 Feb 2021
Last updated
1 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jones L, Rubli Truchard E, Sterie AC, Rhyner Y, Iorio E, Jox RJ. Advance care planning by proxy for residential aged care facility residents: results of a pilot interventional study. Innov Aging. 2026 Apr 7;10(6):igag033. doi: 10.1093/geroni/igag033. eCollection 2026.

    PubMed 42131731

Questions about this trial

What is this clinical trial studying?

A study testing Advance care planning by proxy for health care proxies of people without medical decision making capacity in people with Advanced Dementia and Loss of Medical Decision Making Capacity, run by Ralf J. Jox at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the ACP by proxy intervention (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04779684, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in